ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,138Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1719

$1.39M Total Retail Price of All Prescriptions

Rank: 30 out of 1719

926 Patients Receiving at Least One Drug in Part D
71% Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Georgia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 926 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

31% of this provider’s 926 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,383 877 280 S3 1 5
LISINOPRIL 888 635 162 2 2
LEVOTHYROXINE SODIUM 868 623 140 3 4
SIMVASTATIN 830 605 150 4 3
ALPRAZOLAM 702 452 147 B 5 16
AMLODIPINE BESYLATE 617 473 101 6 1
METFORMIN HCL 598 428 106 7 7
SERTRALINE HCL 558 403 89 8 27
GABAPENTIN 551 328 120 9 12
ZOLPIDEM TARTRATE 551 366 94 9 19
OMEPRAZOLE 545 393 119 11 6
FUROSEMIDE 461 356 100 12 8
HYDROCHLOROTHIAZIDE 399 323 72 13 11
METOPROLOL TARTRATE 387 299 63 14 13
CLOPIDOGREL 370 286 68 15 18
METOPROLOL SUCCINATE 358 279 60 16 26
ATORVASTATIN CALCIUM 347 251 67 17 9
NEXIUM 333 164 62 18 24
PRAVASTATIN SODIUM 289 181 56 19 10
RANITIDINE HCL 270 197 56 20 23
TRAMADOL HCL 262 153 78 21 14
CLONIDINE HCL 243 168 42 22 44
WARFARIN SODIUM 231 185 42 23 29
POTASSIUM CHLORIDE 230 208 50 24 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 189 49 25 21
DONEPEZIL HCL 205 193 30 26 34
MELOXICAM 196 165 49 27 28
AZITHROMYCIN 188 114 147 28 46
TAMSULOSIN HCL 178 138 30 29 35
CARVEDILOL 178 126 41 29 20
LOVASTATIN 177 155 26 31 45
NAPROXEN 177 123 44 31 95
CIPROFLOXACIN HCL 174 132 135 33 67
ALLOPURINOL 171 115 29 34 33
GLIPIZIDE ER 163 130 27 35 92
PROAIR HFA 162 118 65 36 50
CRESTOR 160 133 29 37 31
RAMIPRIL 159 124 29 38 121
LYRICA 157 99 26 39 75
LOSARTAN POTASSIUM 156 110 35 40 17
FENTANYL 152 89 26 S2 41 108
TEMAZEPAM 150 86 30 B 42 94
AMITRIPTYLINE HCL 149 94 27 R 43 68
ALENDRONATE SODIUM 145 112 32 44 54
MONTELUKAST SODIUM 144 112 32 45 48
CITALOPRAM HBR 143 85 28 46 22
OXYCODONE HCL 143 118 24 S2 46 98
CARISOPRODOL 139 71 32 R 48 83
SYNTHROID 133 128* 23 49 55
GLIPIZIDE XL 129 118 24 50 114
ESCITALOPRAM OXALATE 126 96 27 51 58
CLONAZEPAM 125 55 21 B 52 40
PANTOPRAZOLE SODIUM 125 102 31 52 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 124 80 88 54 86
LOSARTAN-HYDROCHLOROTHIAZIDE 119 96 20 55 39
FENOFIBRATE* 119 76 19 55 47
AMLODIPINE BESYLATE-BENAZEPRIL 117 88 16 57 69
LORAZEPAM 113 75 27 B 58 41
ATENOLOL 113 81 19 58 25
QUETIAPINE FUMARATE 111 65 15 A 60 63
DIAZEPAM 111 88 25 B 60 85
GLIPIZIDE 108 79 21 62 57
SPIRONOLACTONE 103 73 22 63 84
VENLAFAXINE HCL ER 100 41 15 64 90
DIOVAN 100 76 17 64 49
CYCLOBENZAPRINE HCL 98 46 37 R 66 62
VALSARTAN-HYDROCHLOROTHIAZIDE 98 85 15 66 73
NAMENDA 97 86 18 68 32
CYMBALTA 91 55 18 69 51
OXYCONTIN 88 <11 <11 S2 70 204
OXYCODONE HCL-ACETAMINOPHEN 86 63 16 S2 71 79
PROMETHAZINE HCL 85 44 31 R 72 82
FLUTICASONE PROPIONATE 84 49 33 73 30
AMOXICILLIN 82 62 69 74 88
SYMBICORT 81 51 26 75 141
KLOR-CON 10 79 50 16 76 122
TRAZODONE HCL 79 38 13 76 38
DOXAZOSIN MESYLATE 78 61 12 78 97
ESTRADIOL 78 53 14 R 78 117
ROPINIROLE HCL 77 72* 18 80 80
SPIRIVA 75 51 26 81 74
TIZANIDINE HCL 74 60 20 82 93
METHYLPREDNISOLONE 74 58 63 82 133
NYSTATIN 73 44 32 84 158
PREDNISONE 72 53 23 85 43
BUSPIRONE HCL 72 57 21 85 118
CELEBREX 71 47 17 87 100
BENAZEPRIL HCL 70 36 16 88 60
EVISTA 69 <11 <11 89 152
COMBIVENT RESPIMAT 68 45 19 90 208
PAROXETINE HCL 68 49 13 90 72
BACLOFEN 66 <11 <11 92 131
JANUVIA 66 55 16 92 66
FLUOXETINE HCL 66 38 15 92 53
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 <11 <11 95 111
LANSOPRAZOLE 63 <11 <11 96 150
LANTUS 63 36 17 96 56
ADVAIR DISKUS 62 41 18 98 59
GEMFIBROZIL 61 34 14 99 115
FAMOTIDINE* 61 <11 <11 99 42
GLIMEPIRIDE 60 <11 <11 101 37
OXYCODONE-ACETAMINOPHEN 59 23 18 S2 102 116
RISPERIDONE 58 53* 13 A 103 70
PREMARIN 57 29 16 R 104 127
ENALAPRIL MALEATE 56 36 11 105 99
VENTOLIN HFA 56 40 17 105 96
DIGOX 55 <11 <11 107 105
IBANDRONATE SODIUM 55 <11 <11 107 261
ADACEL TDAP 54 36 54 109 417
TRIAMCINOLONE ACETONIDE 54 35 42 109 120
DETROL LA 54 <11 <11 109 174
VESICARE 54 <11 <11 109 154
METFORMIN HCL ER 53 <11 <11 113 52
FENOFIBRATE* 53 <11 <11 113 47
GLYBURIDE 52 37 12 R 115 129
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2015.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.